ĀÜĄņĀŅĀ×

Steve Golden serves as Senior Vice President of Finance and Operations at Forge Biologics, and has over 35 years of financial and administrative management expertise in a wide range of organizations in all stages of development, from startā€up through rapid growth and maturity. Prior to joining Forge, Mr. Goden was Senior Director of Finance and Operations at Abeona Therapeutics, a rare disease NASDAQ gene, and cell therapy company. He previously served as Chief Financial Officer of Red5 Pharmaceuticals, a biotech start-up that developed novel diagnostic assays, and SironRx Therapeutics, another biotech start-up that developed dermal wound therapies to reduce scarring. Prior to his biotech experience, Mr. Goden served as Executive Vice President for Cohesant Inc., an investment holding company that acquired, grew, and divested a variety of companies, including GlasCraft Inc., CuraFlo, and Raven Lining Systems. Earlier in his career, Mr. Goden served in senior financial roles at Cole National Corporation (e.g. Pearle Vision, Target Optical, Things Remembered) and Progressive Insurance.